Evidence map›Paper›PMID 26514966›Full record

ArticleChinese journal of integrative medicine2016

Acute and sub-chronic toxicity of tetrandrine in intravenously exposed female BALB/c mice.

Jian-Ping Shi, Shui-Xiu Li, Zheng-Lai Ma, Ai-Li Gao, Yan-Jun Song, Hong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Targeting the two-pore channel 2 in cancer progression and metastasis.Exploration of targeted anti-tumor therapy · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. A critical review: traditional uses, phytochemistry, pharmacology and toxicology ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2020
    Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jian-Ping ShiDepartment of Dermatology First Affiliated Hospital and Institute of Mycology, Jinan University, Guangzhou, 510632, China.
Shui-Xiu LiDepartment of Dermatology First Affiliated Hospital and Institute of Mycology, Jinan University, Guangzhou, 510632, China.
Zheng-Lai MaDepartment of Histology and Embryology, Key Laboratory for Regenerative Medicine of the Ministry of Education, Institute of Fetal-Preterm Labor Medicine, Medical College of Jinan University, Guangzhou, 510632, China.
Ai-Li GaoGuangzhou Institute of Dermstology, Guangzhou, 510095, China.
Yan-Jun SongDepartment of Dermatology First Affiliated Hospital and Institute of Mycology, Jinan University, Guangzhou, 510632, China.
Hong ZhangDepartment of Dermatology First Affiliated Hospital and Institute of Mycology, Jinan University, Guangzhou, 510632, China. tzhangh@jnu.edu.cn.
First Affiliated Hospital of Jinan University · CNGuangzhou Institute of Dermatology · CNJinan University · CNShenzhen Shajing Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the acute and sub-chronic toxicity of intravenously administered tetrandrine (TET) in female BALB/c mice.

methodsThe median lethal dose (LD

resultLD

conclusionsThe overall fifindings of this study indicate that TET is relatively non-toxic from a single dose of 20, 100, 180, 260 or 340 mg/kg, and that up to 90 mg/kg daily for 14 consecutive days can be considered a safe application dose.

Indexed as

Toxicity Tests, AcuteToxicity Tests, ChronicAdministration, IntravenousAnimalsBenzylisoquinolinesBody WeightFemaleMice, Inbred BALB COrgan SpecificityBenzylisoquinolinestetrandrineacute and sub-chronic toxicityChinese medicinefemale BALB/c micetetrandrine

Identifiers

PMID26514966
OpenAlexW2230199217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.